首页 > 最新文献

Journal of Stroke & Cerebrovascular Diseases最新文献

英文 中文
Association between blood pressure and outcome in patients with acute ischemic stroke treated with alteplase 阿替普酶治疗急性缺血性卒中患者血压与预后的关系
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-12-06 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108518
Ole Morten Rønning MD, PhD , Linn Nordby MD , Nicola Logallo MD, PhD , Christopher E Kvistad MD, PhD , Espen Saxhaug Kristoffersen MD, PhD , Håkon Ihle-Hansen MD, PhD , Hege Ihle-Hansen MD, PhD , Vojtech Novotny MD PhD , Ulrike Waje-Andreassen MD, PhD , Halvor Næss MD, PhD , Lars Thomassen MD, PhD , Bente Thommessen MD, PhD

Background

The role of blood pressure (BP) in acute stroke remains unclear. We investigated the impact of BP trajectories during the first 24 hours (h) after hospital admission on outcomes in acute ischemic stroke patients treated with intravenous alteplase.

Methods

In 424 ischemic stroke patients from the NOR-TEST I trial treated with alteplase, we assessed systolic BP (sBP) at baseline, change in sBP between 0 h and 24 h, and increase in sBP over the same period. Outcomes included modified Rankin Scale (mRS) at 3 months, NIHSS at 24 h, and symptomatic intracerebral haemorrhage (sICH) within 48 h.
Logistic and linear regression analyses were used to explore the association of blood pressure trajectories and outcome adjusted for age, sex, time from onset of symptoms to intravenous thrombolysis (IVT) and NIHSS at admittance (NIHSSadm).

Results

Mean sBP at baseline (admittance), 2 h and 24 h were 155, 147 and 142 mmHg, respectively. An increase in sBP from baseline to 24 h was seen in 115 patients (27 %), while 409 showed an overall change. In unadjusted analyses, sBP increase (but not baseline sBP or change in sBP) was associated with worse mRS at 3 months. This remained significant after adjustment (OR 0.933, 95 %CI 0.876 – 0.993). Higher baseline sBP and sBP increase predicted worse NIHSS at 24 h. sBP increase and baseline sBP were also associated with sICH within 48 h, but only baseline sBP remained significant after adjustment (OR 1.022, 95 % CI 1.003–1.042).

Conclusions

An increase in sBP within the first 24 h was associated with worse neurological and functional outcomes at 3 months, while higher baseline sBP was linked to worse neurological outcomes and sICH in acute ischemic stroke patients treated with alteplase.

Clinical trial registration

NCT01949948.
背景:血压(BP)在急性脑卒中中的作用尚不清楚。我们研究了入院后24小时内血压变化轨迹对静脉注射阿替普酶治疗的急性缺血性卒中患者预后的影响。方法:在接受阿替普酶治疗的424例缺血性脑卒中患者中,我们评估了基线时的收缩压(sBP), 0 - 24小时的收缩压变化,以及同期的收缩压升高。结果包括3个月时的改良Rankin量表(mRS), 24小时时的NIHSS, 48小时内的症状性脑出血(siich)。采用Logistic和线性回归分析来探讨血压轨迹与年龄、性别、症状出现到静脉溶栓(IVT)和入院时NIHSS (NIHSSadm)调整后的结果之间的关系。结果:基线(入院)、2h和24h时的平均收缩压分别为155、147和142 mmHg。115例(27%)患者的收缩压从基线升高到24小时,而409例患者的收缩压出现总体变化。在未经调整的分析中,收缩压升高(但不包括基线收缩压或收缩压变化)与3个月时较差的mRS相关。调整后,这仍然是显著的(OR 0.933, 95%CI 0.876 - 0.993)。较高的基线收缩压和收缩压升高预测24 h时NIHSS恶化,48h内收缩压升高和基线收缩压也与sICH相关,但调整后只有基线收缩压仍然显著(OR 1.022, 95% CI 1.003-1.042)。结论:在接受阿替普酶治疗的急性缺血性卒中患者中,最初24小时内收缩压升高与3个月时较差的神经和功能预后相关,而较高的基线收缩压与较差的神经预后和sICH相关。
{"title":"Association between blood pressure and outcome in patients with acute ischemic stroke treated with alteplase","authors":"Ole Morten Rønning MD, PhD ,&nbsp;Linn Nordby MD ,&nbsp;Nicola Logallo MD, PhD ,&nbsp;Christopher E Kvistad MD, PhD ,&nbsp;Espen Saxhaug Kristoffersen MD, PhD ,&nbsp;Håkon Ihle-Hansen MD, PhD ,&nbsp;Hege Ihle-Hansen MD, PhD ,&nbsp;Vojtech Novotny MD PhD ,&nbsp;Ulrike Waje-Andreassen MD, PhD ,&nbsp;Halvor Næss MD, PhD ,&nbsp;Lars Thomassen MD, PhD ,&nbsp;Bente Thommessen MD, PhD","doi":"10.1016/j.jstrokecerebrovasdis.2025.108518","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108518","url":null,"abstract":"<div><h3>Background</h3><div>The role of blood pressure (BP) in acute stroke remains unclear. We investigated the impact of BP trajectories during the first 24 hours (h) after hospital admission on outcomes in acute ischemic stroke patients treated with intravenous alteplase.</div></div><div><h3>Methods</h3><div>In 424 ischemic stroke patients from the NOR-TEST I trial treated with alteplase, we assessed systolic BP (sBP) at baseline, change in sBP between 0 h and 24 h, and increase in sBP over the same period. Outcomes included modified Rankin Scale (mRS) at 3 months, NIHSS at 24 h, and symptomatic intracerebral haemorrhage (sICH) within 48 h.</div><div>Logistic and linear regression analyses were used to explore the association of blood pressure trajectories and outcome adjusted for age, sex, time from onset of symptoms to intravenous thrombolysis (IVT) and NIHSS at admittance (NIHSSadm).</div></div><div><h3>Results</h3><div>Mean sBP at baseline (admittance), 2 h and 24 h were 155, 147 and 142 mmHg, respectively. An increase in sBP from baseline to 24 h was seen in 115 patients (27 %), while 409 showed an overall change. In unadjusted analyses, sBP increase (but not baseline sBP or change in sBP) was associated with worse mRS at 3 months. This remained significant after adjustment (OR 0.933, 95 %CI 0.876 – 0.993). Higher baseline sBP and sBP increase predicted worse NIHSS at 24 h. sBP increase and baseline sBP were also associated with sICH within 48 h, but only baseline sBP remained significant after adjustment (OR 1.022, 95 % CI 1.003–1.042).</div></div><div><h3>Conclusions</h3><div>An increase in sBP within the first 24 h was associated with worse neurological and functional outcomes at 3 months, while higher baseline sBP was linked to worse neurological outcomes and sICH in acute ischemic stroke patients treated with alteplase.</div></div><div><h3>Clinical trial registration</h3><div>NCT01949948.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 1","pages":"Article 108518"},"PeriodicalIF":1.8,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145710658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Based on the PINK1/Parkin signaling pathway, the protective effect of salidroside on cerebral ischemia-reperfusion injury in male rats was investigated 基于PINK1/Parkin信号通路,研究红景天苷对雄性大鼠脑缺血再灌注损伤的保护作用。
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-12-06 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108519
Ting Dong , Haoyu Wang , Yanwei Li , Jun Tan

Objective

Based on the male Sprague-Dawley rats middle cerebral artery occlusion model and SH-SY5Y hypoxia-reoxygenation model, this study systematically evaluated the neuroprotective effect of salidroside (SAL) on cerebral ischemia/reperfusion injury in rats, and explored its possible protective mechanism through PINK1/Parkin signaling axis regulating mitochondrial autophagy.

Materials and methods

Using the middle cerebral artery occlusion (MCAO) model in male Sprague-Dawley rats and the SH-SY5Y cell hypoxia-reoxygenation model, we assessed neurological damage severity through the modified neurological severity scores (NSS). Brain histopathological changes were evaluated using hematoxylin-eosin staining, while the infarct volume in the ischemic brain was assessed with 2,3,5-triphenyltetrazolium chloride (TTC) staining. Transmission electron microscopy was employed to observe mitochondrial ultrastructural alterations in the ischemic brain tissue. Western blotting was used for quantitative analysis of key autophagy-related molecules (PINK1, Parkin), and ROS, MDA, and ferrous ion kit were utilized to evaluate ferroptosis biomarker.

Results

The findings indicate that SAL effectively reduces infarction rates and ameliorates histopathological changes. SAL decreases the formation of reactive oxygen species, malondialdehyde, and ferrous ions by upregulating the expression of PINK1 and Parkin proteins, thereby mitigating apoptosis. Furthermore, SAL significantly inhibits ferroptosis in SH-SY5Y neuroblastoma cells subjected to OGD/R and reduces oxidative stress. The application of the mitochondrial autophagy inhibitor Mdivi-1 enhances the protective effect of SAL against ferroptosis in both MCAO and OGD/R models. Therefore, we draw the following conclusions: In the rat cerebral ischemia-reperfusion injury model and the SH-SY5Y cell oxygen-glucose deprivation/reoxygenation (OGD/R) model, iron death was found to be increased. Pre-treatment with salidroside was able to reduce the occurrence of iron death in both the cerebral ischemia-reperfusion injury model and the cellular OGD/R model.

Conclusions

Salidroside may inhibit iron death by activating the PINK 1 / Parkin signaling pathway and thereby reduce cerebral ischemia-reperfusion injury. Targeted regulation of this pathway may become an important strategy to interfere with CIRI.
目的:基于雄性Sprague-Dawley大鼠大脑中动脉闭塞模型和SH-SY5Y缺氧复氧模型,系统评价红红草苷(SAL)对大鼠脑缺血再灌注损伤的神经保护作用,并通过PINK1/Parkin信号轴调节线粒体自噬,探讨其可能的保护机制。材料与方法:采用sd - dawley雄性大鼠大脑中动脉闭塞(MCAO)模型和SH-SY5Y细胞缺氧复氧模型,采用改良神经损伤严重程度评分法(NSS)评估神经损伤严重程度。采用苏木精-伊红染色评估脑组织病理学改变,2,3,5-三苯四唑氯(TTC)染色评估缺血脑梗死体积。透射电镜观察缺血脑组织线粒体超微结构变化。采用Western blotting定量分析自噬相关关键分子(PINK1、Parkin),采用ROS、MDA、亚铁离子试剂盒评价铁凋亡生物标志物。结果:SAL能有效降低梗死发生率,改善组织病理改变。SAL通过上调PINK1和Parkin蛋白的表达,减少活性氧、丙二醛和亚铁离子的形成,从而减轻细胞凋亡。此外,SAL显著抑制OGD/R下SH-SY5Y神经母细胞瘤细胞的铁下垂,并降低氧化应激。在MCAO和OGD/R模型中,线粒体自噬抑制剂Mdivi-1的应用增强了SAL对铁凋亡的保护作用。因此,我们得出以下结论:在大鼠脑缺血再灌注损伤模型和SH-SY5Y细胞氧-葡萄糖剥夺/再氧合(OGD/R)模型中,发现铁死亡增加。红景天苷预处理可以减少脑缺血再灌注损伤模型和细胞OGD/R模型中铁死亡的发生。结论:红景天苷可能通过激活PINK 1 / Parkin信号通路抑制铁死亡,从而减轻脑缺血再灌注损伤。靶向调控这一通路可能成为干扰CIRI的重要策略。
{"title":"Based on the PINK1/Parkin signaling pathway, the protective effect of salidroside on cerebral ischemia-reperfusion injury in male rats was investigated","authors":"Ting Dong ,&nbsp;Haoyu Wang ,&nbsp;Yanwei Li ,&nbsp;Jun Tan","doi":"10.1016/j.jstrokecerebrovasdis.2025.108519","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108519","url":null,"abstract":"<div><h3>Objective</h3><div>Based on the male Sprague-Dawley rats middle cerebral artery occlusion model and SH-SY5Y hypoxia-reoxygenation model, this study systematically evaluated the neuroprotective effect of salidroside (SAL) on cerebral ischemia/reperfusion injury in rats, and explored its possible protective mechanism through PINK1/Parkin signaling axis regulating mitochondrial autophagy.</div></div><div><h3>Materials and methods</h3><div>Using the middle cerebral artery occlusion (MCAO) model in male Sprague-Dawley rats and the SH-SY5Y cell hypoxia-reoxygenation model, we assessed neurological damage severity through the modified neurological severity scores (NSS). Brain histopathological changes were evaluated using hematoxylin-eosin staining, while the infarct volume in the ischemic brain was assessed with 2,3,5-triphenyltetrazolium chloride (TTC) staining. Transmission electron microscopy was employed to observe mitochondrial ultrastructural alterations in the ischemic brain tissue. Western blotting was used for quantitative analysis of key autophagy-related molecules (PINK1, Parkin), and ROS, MDA, and ferrous ion kit were utilized to evaluate ferroptosis biomarker.</div></div><div><h3>Results</h3><div>The findings indicate that SAL effectively reduces infarction rates and ameliorates histopathological changes. SAL decreases the formation of reactive oxygen species, malondialdehyde, and ferrous ions by upregulating the expression of PINK1 and Parkin proteins, thereby mitigating apoptosis. Furthermore, SAL significantly inhibits ferroptosis in SH-SY5Y neuroblastoma cells subjected to OGD/R and reduces oxidative stress. The application of the mitochondrial autophagy inhibitor Mdivi-1 enhances the protective effect of SAL against ferroptosis in both MCAO and OGD/R models. Therefore, we draw the following conclusions: In the rat cerebral ischemia-reperfusion injury model and the SH-SY5Y cell oxygen-glucose deprivation/reoxygenation (OGD/R) model, iron death was found to be increased. Pre-treatment with salidroside was able to reduce the occurrence of iron death in both the cerebral ischemia-reperfusion injury model and the cellular OGD/R model.</div></div><div><h3>Conclusions</h3><div>Salidroside may inhibit iron death by activating the PINK 1 / Parkin signaling pathway and thereby reduce cerebral ischemia-reperfusion injury. Targeted regulation of this pathway may become an important strategy to interfere with CIRI.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 1","pages":"Article 108519"},"PeriodicalIF":1.8,"publicationDate":"2025-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145710645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative analysis of SCALE-CTP and RAPID in determining the affected brain volumes of patients with ischemic stroke SCALE-CTP与RAPID测定缺血性脑卒中患者脑容量的比较分析。
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-12-05 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108517
Jundong Hwang , Hyeon Sik Yang , Gi-Youn Kim , Regina EY Kim , Minho Lee , Donghyeon Kim , Jin Wook Choi , Woo Sang Jung , Kijeong Lee

Background

Computed tomography perfusion (CTP) is widely used to treat acute strokes. The affected brain volume, measured based on the threshold value in the calculated CTP map, has helped guide treatment decisions. We proposed a new software program developed for CTP analysis, SCALE-CTP, and compared the affected brain volumes estimated using RAPID and SCALE-CTP.

Methods

We recruited 362 individuals from the local hospital to evaluate the concordance between SCALE-CTP and RAPID in predicting affected brain volumes, including relative cerebral blood flow (rCBF) <30 % and time-to-maximum concentration (Tmax) > 6 s, and the mismatch volumes. Concordance correlation coefficients (CCC) and Bland–Altman plots were used to assess agreement. Subgroup analyses and comparisons with DWI-derived infarction areas were also performed, along with an evaluation of differences in clinical decision-making.

Results

The calculated volumes from two different software showed excellent concordance (rCBF < 30 % volume: 0.91, Tmax > 6s: 0.88 volume, mismatch volume: 0.82). The concordance between the two software programs remains excellent in the subgroup analysis. In the subset of 38 cases, the differences between DWI-derived infarction area and rCBF < 30 % volume from both software were similar, while SCALE-CTP showed more variability. Their differences in clinical decision making were slightly different.

Conclusion

SCALE-CTP demonstrated strong agreement with RAPID in predicting affected brain volumes and shows potential as a reliable tool for guiding hyperacute ischemic stroke treatment. Further validation is needed to confirm its clinical utility.
背景:计算机断层扫描灌注(CTP)被广泛应用于急性脑卒中的治疗。根据计算的CTP图中的阈值来测量受影响的脑容量,有助于指导治疗决策。我们提出了一种新的CTP分析软件,SCALE-CTP,并比较了使用RAPID和SCALE-CTP估计的受影响的脑容量。方法:我们从当地医院招募了362名患者,评估SCALE-CTP和RAPID在预测影响脑容量(包括相对脑血流量(rCBF) 6s和不匹配容量)方面的一致性。一致性相关系数(CCC)和Bland-Altman图用于评估一致性。还进行了亚组分析和与dwi衍生梗死区域的比较,并评估了临床决策的差异。结果:两种不同软件计算的体积具有良好的一致性(rCBF < 30%体积:0.91,Tmax bbb6s体积:0.88,错配体积:0.82)。在亚群分析中,两个软件程序之间的一致性仍然很好。在38例的子集中,两种软件得出的dwi衍生的梗死面积和rCBF < 30%体积之间的差异相似,而SCALE-CTP显示出更多的可变性。他们在临床决策方面的差异略有不同。结论:SCALE-CTP与RAPID在预测受影响脑容量方面表现出强烈的一致性,并显示出作为指导超急性缺血性脑卒中治疗的可靠工具的潜力。需要进一步验证以确认其临床应用。
{"title":"A comparative analysis of SCALE-CTP and RAPID in determining the affected brain volumes of patients with ischemic stroke","authors":"Jundong Hwang ,&nbsp;Hyeon Sik Yang ,&nbsp;Gi-Youn Kim ,&nbsp;Regina EY Kim ,&nbsp;Minho Lee ,&nbsp;Donghyeon Kim ,&nbsp;Jin Wook Choi ,&nbsp;Woo Sang Jung ,&nbsp;Kijeong Lee","doi":"10.1016/j.jstrokecerebrovasdis.2025.108517","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108517","url":null,"abstract":"<div><h3>Background</h3><div>Computed tomography perfusion (CTP) is widely used to treat acute strokes. The affected brain volume, measured based on the threshold value in the calculated CTP map, has helped guide treatment decisions. We proposed a new software program developed for CTP analysis, SCALE-CTP, and compared the affected brain volumes estimated using RAPID and SCALE-CTP.</div></div><div><h3>Methods</h3><div>We recruited 362 individuals from the local hospital to evaluate the concordance between SCALE-CTP and RAPID in predicting affected brain volumes, including relative cerebral blood flow (rCBF) &lt;30 % and time-to-maximum concentration (Tmax) &gt; 6 s, and the mismatch volumes. Concordance correlation coefficients (CCC) and Bland–Altman plots were used to assess agreement. Subgroup analyses and comparisons with DWI-derived infarction areas were also performed, along with an evaluation of differences in clinical decision-making.</div></div><div><h3>Results</h3><div>The calculated volumes from two different software showed excellent concordance (rCBF &lt; 30 % volume: 0.91, Tmax &gt; 6s: 0.88 volume, mismatch volume: 0.82). The concordance between the two software programs remains excellent in the subgroup analysis. In the subset of 38 cases, the differences between DWI-derived infarction area and rCBF &lt; 30 % volume from both software were similar, while SCALE-CTP showed more variability. Their differences in clinical decision making were slightly different.</div></div><div><h3>Conclusion</h3><div>SCALE-CTP demonstrated strong agreement with RAPID in predicting affected brain volumes and shows potential as a reliable tool for guiding hyperacute ischemic stroke treatment. Further validation is needed to confirm its clinical utility.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 2","pages":"Article 108517"},"PeriodicalIF":1.8,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145703757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrated TyG index and eGDR measure enhances stroke risk stratification in early cardiovascular-kidney-metabolic syndrome: A prospective national cohort analysis 综合TyG指数和eGDR测量增强早期心血管-肾-代谢综合征卒中风险分层:一项前瞻性国家队列分析
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-12-05 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108516
Xiaolei Wang, Hongfeng Sun, Taojing Zhang, Hui Zhou

Background

The triglyceride-glucose (TyG) index and estimated glucose disposal rate (eGDR) are established markers of insulin resistance (IR), yet their combined role in predicting stroke among individuals with early-stage cardiovascular-kidney-metabolic (CKM) syndrome remains unclear.

Methods

We included 4,414 participants from the China Health and Retirement Longitudinal Study (CHARLS) with baseline (2011) and follow-up (2015) data. TyG-eGDR was calculated at both timepoints, and cumulative exposure was derived. K-means clustering categorized participants into three dynamic trajectory groups. Cox proportional hazards models evaluated stroke risk, restricted cubic splines (RCS) tested nonlinearity, and receiver operating characteristic (ROC) curves assessed predictive performance.

Results

Over the follow-up period, 219 stroke events occurred. Compared to the low TyG-eGDR trajectory group, the high-trajectory group had a 2.84-fold increased stroke risk (HR = 2.84, 95 % CI: 1.67–4.81). Participants with the highest cumulative TyG-eGDR exposure exhibited a 4.28-fold increased stroke risk (HR = 4.28, 95 % CI: 2.66–6.89), while those with high baseline levels had a 3.46-fold elevated risk (HR = 3.46, 95 % CI: 1.82–6.58). RCS analyses revealed significant nonlinear relationships between TyG-eGDR indices and stroke (P < 0.05).

Conclusions

Sustained high TyG-eGDR levels predict stroke risk in early CKM syndrome, supporting its integration into routine metabolic cerebrovascular risk assessment.
背景:甘油三酯-葡萄糖(TyG)指数和估计葡萄糖处置率(eGDR)是胰岛素抵抗(IR)的既定指标,但它们在预测早期心血管-肾脏代谢(CKM)综合征患者中风中的联合作用尚不清楚。方法:我们纳入了来自中国健康与退休纵向研究(CHARLS)的4,414名参与者,包括基线(2011年)和随访(2015年)数据。在两个时间点计算TyG-eGDR,并得出累积暴露量。K-means聚类将参与者分为三个动态轨迹组。Cox比例风险模型评估卒中风险,限制性三次样条(RCS)测试非线性,受试者工作特征(ROC)曲线评估预测效果。结果:随访期间共发生219例脑卒中事件。与低TyG-eGDR轨迹组相比,高轨迹组卒中风险增加2.84倍(HR = 2.84,95% CI: 1.67-4.81)。累积TyG-eGDR暴露最高的参与者卒中风险增加4.28倍(HR = 4.28,95% CI: 2.66-6.89),而基线水平高的参与者卒中风险增加3.46倍(HR = 3.46,95% CI: 1.82-6.58)。RCS分析显示TyG-eGDR指数与卒中之间存在显著的非线性关系(P < 0.05)。结论:TyG-eGDR持续高水平预测早期CKM综合征卒中风险,支持将其纳入常规代谢性脑血管风险评估。
{"title":"Integrated TyG index and eGDR measure enhances stroke risk stratification in early cardiovascular-kidney-metabolic syndrome: A prospective national cohort analysis","authors":"Xiaolei Wang,&nbsp;Hongfeng Sun,&nbsp;Taojing Zhang,&nbsp;Hui Zhou","doi":"10.1016/j.jstrokecerebrovasdis.2025.108516","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108516","url":null,"abstract":"<div><h3>Background</h3><div>The triglyceride-glucose (TyG) index and estimated glucose disposal rate (eGDR) are established markers of insulin resistance (IR), yet their combined role in predicting stroke among individuals with early-stage cardiovascular-kidney-metabolic (CKM) syndrome remains unclear.</div></div><div><h3>Methods</h3><div>We included 4,414 participants from the China Health and Retirement Longitudinal Study (CHARLS) with baseline (2011) and follow-up (2015) data. TyG-eGDR was calculated at both timepoints, and cumulative exposure was derived. K-means clustering categorized participants into three dynamic trajectory groups. Cox proportional hazards models evaluated stroke risk, restricted cubic splines (RCS) tested nonlinearity, and receiver operating characteristic (ROC) curves assessed predictive performance.</div></div><div><h3>Results</h3><div>Over the follow-up period, 219 stroke events occurred. Compared to the low TyG-eGDR trajectory group, the high-trajectory group had a 2.84-fold increased stroke risk (HR = 2.84, 95 % CI: 1.67–4.81). Participants with the highest cumulative TyG-eGDR exposure exhibited a 4.28-fold increased stroke risk (HR = 4.28, 95 % CI: 2.66–6.89), while those with high baseline levels had a 3.46-fold elevated risk (HR = 3.46, 95 % CI: 1.82–6.58). RCS analyses revealed significant nonlinear relationships between TyG-eGDR indices and stroke (<em>P</em> &lt; 0.05).</div></div><div><h3>Conclusions</h3><div>Sustained high TyG-eGDR levels predict stroke risk in early CKM syndrome, supporting its integration into routine metabolic cerebrovascular risk assessment.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 1","pages":"Article 108516"},"PeriodicalIF":1.8,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145703744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cerebroprotection in acute ischemic stroke: Perspectives on combining cerebrolysin with recanalization therapy 急性缺血性脑卒中的脑保护:溶脑素联合再通治疗的观点。
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-12-03 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108515
Marc Ribó , Jacek Staszewski , Steven R. Zeiler , Sławomir Michalak , Ahmed El Bassiouny , Fernando Gongora-Rivera , Zdravka Poljakovic , Dina R Khasanova , Mikhail N Kalinin , Aurauma Chutinet , Roni Eichel , Klaudyna Kojder , Marissa Ong , Marina Roje Bedeković , Chien-Hung Chang , Minwoo Lee , Peter Quitasol , Alexander Tsiskaridse , Natan M Bornstein
This article provides perspectives on the use of Cerebrolysin as an adjunct treatment to reperfusion therapy in acute ischemic stroke (AIS). In the evolving landscape of AIS reperfusion therapy, we hypothesize that adjunctive cerebroprotective therapy, such as Cerebrolysin, is likely to further improve patient outcomes. Beyond its established neurorecovery benefits, recent data indicate that Cerebrolysin also offers protection to the neurovascular unit and the blood-brain barrier. This paper introduces the CErebrolysin in RECanalization And Perfusion (CERECAP) program, a collaborative initiative of independent academic investigations exploring the favorable trends of Cerebrolysin in reperfusion. The CERECAP program has generated compelling data demonstrating Cerebrolysin’s alignment with current AIS reperfusion therapy concepts, particularly its role in early intervention targeting multiple pathways. We review these studies and discuss the critical need to clearly define the patient population that benefit most from adjunctive Cerebrolysin therapy in AIS.
本文就脑溶血素作为急性缺血性脑卒中再灌注治疗的辅助治疗提供了一些观点。在AIS再灌注治疗不断发展的前景中,我们假设辅助脑保护治疗,如脑溶血素,可能会进一步改善患者的预后。除了其既定的神经恢复的好处,最近的数据表明,脑溶素也提供保护神经血管单位和血脑屏障。本文介绍了脑溶血素再通灌注(CERECAP)计划,这是一项独立学术研究的合作倡议,旨在探索脑溶血素在再灌注中的有利趋势。CERECAP项目产生了令人信服的数据,证明了脑溶血素与当前AIS再灌注治疗概念的一致性,特别是其在针对多途径的早期干预中的作用。我们回顾了这些研究,并讨论了在AIS中明确定义从辅助脑溶素治疗中获益最多的患者群体的迫切需要。
{"title":"Cerebroprotection in acute ischemic stroke: Perspectives on combining cerebrolysin with recanalization therapy","authors":"Marc Ribó ,&nbsp;Jacek Staszewski ,&nbsp;Steven R. Zeiler ,&nbsp;Sławomir Michalak ,&nbsp;Ahmed El Bassiouny ,&nbsp;Fernando Gongora-Rivera ,&nbsp;Zdravka Poljakovic ,&nbsp;Dina R Khasanova ,&nbsp;Mikhail N Kalinin ,&nbsp;Aurauma Chutinet ,&nbsp;Roni Eichel ,&nbsp;Klaudyna Kojder ,&nbsp;Marissa Ong ,&nbsp;Marina Roje Bedeković ,&nbsp;Chien-Hung Chang ,&nbsp;Minwoo Lee ,&nbsp;Peter Quitasol ,&nbsp;Alexander Tsiskaridse ,&nbsp;Natan M Bornstein","doi":"10.1016/j.jstrokecerebrovasdis.2025.108515","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108515","url":null,"abstract":"<div><div>This article provides perspectives on the use of Cerebrolysin as an adjunct treatment to reperfusion therapy in acute ischemic stroke (AIS). In the evolving landscape of AIS reperfusion therapy, we hypothesize that adjunctive cerebroprotective therapy, such as Cerebrolysin, is likely to further improve patient outcomes. Beyond its established neurorecovery benefits, recent data indicate that Cerebrolysin also offers protection to the neurovascular unit and the blood-brain barrier. This paper introduces the CErebrolysin in RECanalization And Perfusion (CERECAP) program, a collaborative initiative of independent academic investigations exploring the favorable trends of Cerebrolysin in reperfusion. The CERECAP program has generated compelling data demonstrating Cerebrolysin’s alignment with current AIS reperfusion therapy concepts, particularly its role in early intervention targeting multiple pathways. We review these studies and discuss the critical need to clearly define the patient population that benefit most from adjunctive Cerebrolysin therapy in AIS.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 1","pages":"Article 108515"},"PeriodicalIF":1.8,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145688917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improved outcome prediction in large vessel occlusion stroke: A comparison of Tmax-based hypoperfusion ratios HIR10/4 and HIR10/6 改进的大血管闭塞卒中预后预测:基于tmax的低灌注比HIR10/4和HIR10/6的比较
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-12-01 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108504
Jeewon Chon MA , Ashley Treanor BS , Andrew C. Pickles BS , William Y. Shin BA , Ronak H. Jani MD , John T. Tsiang MD , Amy Wozniak MS , Anthony W. Kam MD, PhD , David P. Pasquale MD , Joseph C. Serrone MD , Brandon J. Bond MD

Background

The hypoperfusion intensity ratio (HIR), derived from CT perfusion (CTP), reflects collateral flow quality, but its optimal formulation remains unsettled.

Objective

To compare the prognostic utility of conventional HIR10/6 (time-to-maximum [Tmax] >10s / >6 s) with an alternative HIR10/4 (Tmax >10s / >4 s) in patients undergoing endovascular thrombectomy (EVT).

Methods

We retrospectively analyzed consecutive large-vessel occlusion (LVO) strokes treated with EVT at our quaternary academic medical center (2015–2024). CTP was processed using RAPID software. Primary outcomes were modified Rankin Scale (mRS) at discharge and at 90 days. Secondary outcomes included National Institutes of Health Stroke Scale (NIHSS) at discharge and hemorrhagic transformation on follow-up imaging. Ordinal and linear regression models were adjusted for age, sex, vascular risk factors, intravenous thrombolysis, presentation window, and transfer status. Receiver operating characteristic (ROC) curves assessed discriminative performance.

Results

Among 280 patients (mean age 70 ±15 years; 49 % male), mean HIR10/6 was 0.418 and HIR10/4 was 0.241. Each 0.1-unit increase in HIR10/4 translated to 31 % higher odds of worse mRS at discharge (adjusted odds ratio [aOR] 1.31, 95 % CI 1.12–1.54; p=0.001), 24 % higher odds of worse mRS at 90 days (aOR 1.24, 95 % CI 1.04–1.48; p=0.016), and higher discharge NIHSS (β=0.88, 95 % CI 0.05–1.71; p=0.039). HIR10/6 showed weaker associations and was not significant for discharge NIHSS. Neither HIR metric demonstrated meaningful discrimination for hemorrhagic transformation or dichotomized outcomes (area under the curve [AUC] 0.50–0.52).

Conclusions

Incorporating mildly delayed tissue (Tmax >4 s) may enhance the physiologic sensitivity of HIR. HIR10/4 may be a potential prognostic biomarker; however, prospective validation is needed, and its standalone ability to discriminate binary outcomes remains limited.
背景:由CT灌注(CTP)得出的低灌注强度比(HIR)反映了侧支血流质量,但其最佳公式仍未确定。目的:比较常规HIR10/6(时间至最大[Tmax] >0秒 / >6s)与替代HIR10/4 (Tmax >0秒 / >4s)在血管内取栓(EVT)患者中的预后价值。方法:回顾性分析2015-2024年在我院第四医学中心接受EVT治疗的连续大血管闭塞(LVO)脑卒中患者。采用RAPID软件对CTP进行处理。主要结果是出院时和90天时的修正Rankin量表(mRS)。次要结果包括出院时的美国国立卫生研究院卒中量表(NIHSS)和随访成像时的出血转化。排序和线性回归模型根据年龄、性别、血管危险因素、静脉溶栓、呈现窗口和转移状态进行调整。受试者工作特征(ROC)曲线评估鉴别表现。结果:280例患者(平均年龄70 ±15岁,男性49%),平均HIR10/6为0.418,HIR10/4为0.241。HIR10/4每增加0.1个单位,出院时mRS恶化的几率增加31%(校正比值比[aOR] 1.31, 95% CI 1.12-1.54; p=0.001), 90天mRS恶化的几率增加24% (aOR 1.24, 95% CI 1.04-1.48; p=0.016),出院时NIHSS升高(β=0.88, 95% CI 0.05-1.71; p=0.039)。HIR10/6与出院NIHSS的相关性较弱,且不显著。两项HIR指标均未显示出出血转化或二分类结果的显著区别(曲线下面积[AUC] 0.50-0.52)。结论:纳入轻度延迟组织(Tmax b>s)可提高HIR的生理敏感性。HIR10/4可能是一个潜在的预后生物标志物;然而,需要前瞻性验证,并且其单独区分二元结果的能力仍然有限。
{"title":"Improved outcome prediction in large vessel occlusion stroke: A comparison of Tmax-based hypoperfusion ratios HIR10/4 and HIR10/6","authors":"Jeewon Chon MA ,&nbsp;Ashley Treanor BS ,&nbsp;Andrew C. Pickles BS ,&nbsp;William Y. Shin BA ,&nbsp;Ronak H. Jani MD ,&nbsp;John T. Tsiang MD ,&nbsp;Amy Wozniak MS ,&nbsp;Anthony W. Kam MD, PhD ,&nbsp;David P. Pasquale MD ,&nbsp;Joseph C. Serrone MD ,&nbsp;Brandon J. Bond MD","doi":"10.1016/j.jstrokecerebrovasdis.2025.108504","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108504","url":null,"abstract":"<div><h3>Background</h3><div>The hypoperfusion intensity ratio (HIR), derived from CT perfusion (CTP), reflects collateral flow quality, but its optimal formulation remains unsettled.</div></div><div><h3>Objective</h3><div>To compare the prognostic utility of conventional HIR<sub>10/6</sub> (time-to-maximum [T<sub>max</sub>] &gt;10s / &gt;6 s) with an alternative HIR<sub>10/4</sub> (T<sub>max</sub> &gt;10s / &gt;4 s) in patients undergoing endovascular thrombectomy (EVT).</div></div><div><h3>Methods</h3><div>We retrospectively analyzed consecutive large-vessel occlusion (LVO) strokes treated with EVT at our quaternary academic medical center (2015–2024). CTP was processed using RAPID software. Primary outcomes were modified Rankin Scale (mRS) at discharge and at 90 days. Secondary outcomes included National Institutes of Health Stroke Scale (NIHSS) at discharge and hemorrhagic transformation on follow-up imaging. Ordinal and linear regression models were adjusted for age, sex, vascular risk factors, intravenous thrombolysis, presentation window, and transfer status. Receiver operating characteristic (ROC) curves assessed discriminative performance.</div></div><div><h3>Results</h3><div>Among 280 patients (mean age 70 ±15 years; 49 % male), mean HIR<sub>10/6</sub> was 0.418 and HIR<sub>10/4</sub> was 0.241. Each 0.1-unit increase in HIR<sub>10/4</sub> translated to 31 % higher odds of worse mRS at discharge (adjusted odds ratio [aOR] 1.31, 95 % CI 1.12–1.54; <em>p</em>=0.001), 24 % higher odds of worse mRS at 90 days (aOR 1.24, 95 % CI 1.04–1.48; <em>p</em>=0.016), and higher discharge NIHSS (β=0.88, 95 % CI 0.05–1.71; <em>p</em>=0.039). HIR<sub>10/6</sub> showed weaker associations and was not significant for discharge NIHSS. Neither HIR metric demonstrated meaningful discrimination for hemorrhagic transformation or dichotomized outcomes (area under the curve [AUC] 0.50–0.52).</div></div><div><h3>Conclusions</h3><div>Incorporating mildly delayed tissue (T<sub>max</sub> &gt;4 s) may enhance the physiologic sensitivity of HIR. HIR<sub>10/4</sub> may be a potential prognostic biomarker; however, prospective validation is needed, and its standalone ability to discriminate binary outcomes remains limited.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 12","pages":"Article 108504"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age at natural menopause and stroke: A U-shaped association in the health and retirement study 自然绝经年龄与中风:健康与退休研究中的u型关联。
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-12-01 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108497
QinFeng Zeng , Wenjia Zhang, Yingzhi Liu, Weijun Yang, XiaoLing Wu, Jieding Li

Background

The association between age at natural menopause and cerebrovascular risk is unclear. This study investigates non-linear relationships, effect modification, mediation, and long-term stroke-free survival in postmenopausal women.

Methods

We analyzed 9,159 postmenopausal women from the Health and Retirement Study. Menopause age was categorized (<40, 40–44, 45–49, 50–55, >55) and modeled continuously. Stroke outcomes were derived from self-reports and linked Medicare claims. We used multivariable logistic regression with restricted cubic splines, interaction terms among hypertension, diabetes, and hypercholesterolemia, structural equation modeling for mediation, and Kaplan-Meier/Cox models for survival analysis.

Results

Each additional year of later menopause was linked to lower stroke odds (OR 0.935, 95 % CI 0.922–0.948). Compared to the 50–55 age group, those with menopause <45 years (OR 2.76, 95 % CI 2.09–3.47) and 45–49 years (OR 2.08, 95 % CI 1.72–2.62) had higher risks. Spline analysis indicated a U-shaped curve, with the lowest risk at ages 50–52. Stroke-free survival differed significantly across groups (log-rank p = 0.0017), particularly worse with premature menopause.

Conclusions

Age at natural menopause exhibits a U-shaped association with stroke risk, emphasizing the importance of timing in individualized prevention strategies.
背景:自然绝经年龄与脑血管风险之间的关系尚不清楚。本研究探讨了绝经后妇女的非线性关系、效应修正、调解和长期无卒中生存。方法:我们分析了9159名来自健康与退休研究的绝经后妇女。绝经年龄分类(55岁)并连续建模。中风的结果来源于自我报告和相关的医疗保险索赔。我们使用限制三次样条的多变量逻辑回归,高血压、糖尿病和高胆固醇血症之间的相互作用项,结构方程模型作为中介,Kaplan-Meier/Cox模型用于生存分析。结果:绝经时间每晚一年与卒中风险降低相关(OR 0.935, 95% CI 0.922-0.948)。结论:自然绝经年龄与卒中风险呈u型相关,强调了个体化预防策略中时机的重要性。
{"title":"Age at natural menopause and stroke: A U-shaped association in the health and retirement study","authors":"QinFeng Zeng ,&nbsp;Wenjia Zhang,&nbsp;Yingzhi Liu,&nbsp;Weijun Yang,&nbsp;XiaoLing Wu,&nbsp;Jieding Li","doi":"10.1016/j.jstrokecerebrovasdis.2025.108497","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108497","url":null,"abstract":"<div><h3>Background</h3><div>The association between age at natural menopause and cerebrovascular risk is unclear. This study investigates non-linear relationships, effect modification, mediation, and long-term stroke-free survival in postmenopausal women.</div></div><div><h3>Methods</h3><div>We analyzed 9,159 postmenopausal women from the Health and Retirement Study. Menopause age was categorized (&lt;40, 40–44, 45–49, 50–55, &gt;55) and modeled continuously. Stroke outcomes were derived from self-reports and linked Medicare claims. We used multivariable logistic regression with restricted cubic splines, interaction terms among hypertension, diabetes, and hypercholesterolemia, structural equation modeling for mediation, and Kaplan-Meier/Cox models for survival analysis.</div></div><div><h3>Results</h3><div>Each additional year of later menopause was linked to lower stroke odds (OR 0.935, 95 % CI 0.922–0.948). Compared to the 50–55 age group, those with menopause &lt;45 years (OR 2.76, 95 % CI 2.09–3.47) and 45–49 years (OR 2.08, 95 % CI 1.72–2.62) had higher risks. Spline analysis indicated a U-shaped curve, with the lowest risk at ages 50–52. Stroke-free survival differed significantly across groups (log-rank <em>p</em> = 0.0017), particularly worse with premature menopause.</div></div><div><h3>Conclusions</h3><div>Age at natural menopause exhibits a U-shaped association with stroke risk, emphasizing the importance of timing in individualized prevention strategies.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 12","pages":"Article 108497"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145575177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of holistic nursing intervention based on harmonious nursing theory on patients in stroke recovery period 基于和谐护理理论的整体护理干预对脑卒中恢复期患者的影响
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-12-01 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108507
Xiaozhu Yu Master of Nursing (Lecturer) , Xichao Xia Doctor of Medicine (Professor) , Yanfang Guo Master of Nursing (Senior Nurse) , Yuhong Wu Master of Nursing (Chief Nurse)

Objective

To systematically analyze the application effect of holistic nursing intervention based on Harmonious Nursing Theory in patients during stroke recovery period, and provide evidence-based basis for optimizing clinical nursing programs.

Methods

Patients in the stroke recovery period were divided into observation group and control group with 83 cases each by random number table method. The control group received routine nursing intervention, while the observation group received holistic nursing intervention based on Harmonious Nursing Theory. The Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), Herth Hope Index (HHI), SF-36 Short-Form Health Survey, and nursing satisfaction questionnaire were used to compare the differences in negative emotions, hope level, quality of life, and satisfaction between the two groups of patients before and after intervention.

Results

After the intervention, the self-reported anxiety score of the observation group was (42.87±17.32) and the self-reported depression score was (45.28±16.67), both significantly lower than those of the control group [(51.59±15.19) and (50.51±15.52), respectively; all P<0.05]. The total score of hope level in the observation group was (40.87±6.03), which was higher than that in the control group [(34.78±5.93); P<0.05]. The scores of all 8 dimensions of health status in the observation group were higher than those in the control group (all P<0.05). The nursing satisfaction rate of the observation group was 92.77%, which was higher than 78.31% of the control group (P<0.05).

Conclusion

Implementing holistic nursing intervention based on Harmonious Nursing Theory for patients in stroke recovery period can effectively alleviate negative emotions, improve hope level and quality of life, as well as enhance nursing satisfaction, which has high clinical promotion value.
目的系统分析基于和谐护理理论的整体护理干预在脑卒中恢复期患者中的应用效果,为优化临床护理方案提供循证依据。方法采用随机数字表法将脑卒中恢复期患者分为观察组和对照组各83例。对照组采用常规护理干预,观察组采用基于和谐护理理论的整体护理干预。采用焦虑自评量表(SAS)、抑郁自评量表(SDS)、赫斯希望指数(HHI)、SF-36简易健康问卷、护理满意度问卷比较干预前后两组患者在消极情绪、希望水平、生活质量、满意度等方面的差异。结果干预后,观察组焦虑自我报告得分为(42.87±17.32)分,抑郁自我报告得分为(45.28±16.67)分,均显著低于对照组(51.59±15.19)分和(50.51±15.52)分;所有术;0.05]。观察组患者希望水平总分为(40.87±6.03)分,高于对照组(34.78±5.93)分;术中,0.05]。观察组患者健康状况8个维度得分均高于对照组(p < 0.05)。观察组护理满意率为92.77%,高于对照组的78.31% (P<0.05)。结论对脑卒中恢复期患者实施基于和谐护理理论的整体护理干预,可有效缓解患者的负性情绪,提高患者的希望水平和生活质量,提高护理满意度,具有较高的临床推广价值。
{"title":"Effect of holistic nursing intervention based on harmonious nursing theory on patients in stroke recovery period","authors":"Xiaozhu Yu Master of Nursing (Lecturer) ,&nbsp;Xichao Xia Doctor of Medicine (Professor) ,&nbsp;Yanfang Guo Master of Nursing (Senior Nurse) ,&nbsp;Yuhong Wu Master of Nursing (Chief Nurse)","doi":"10.1016/j.jstrokecerebrovasdis.2025.108507","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108507","url":null,"abstract":"<div><h3>Objective</h3><div>To systematically analyze the application effect of holistic nursing intervention based on Harmonious Nursing Theory in patients during stroke recovery period, and provide evidence-based basis for optimizing clinical nursing programs.</div></div><div><h3>Methods</h3><div>Patients in the stroke recovery period were divided into observation group and control group with 83 cases each by random number table method. The control group received routine nursing intervention, while the observation group received holistic nursing intervention based on Harmonious Nursing Theory. The Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), Herth Hope Index (HHI), SF-36 Short-Form Health Survey, and nursing satisfaction questionnaire were used to compare the differences in negative emotions, hope level, quality of life, and satisfaction between the two groups of patients before and after intervention.</div></div><div><h3>Results</h3><div>After the intervention, the self-reported anxiety score of the observation group was (42.87±17.32) and the self-reported depression score was (45.28±16.67), both significantly lower than those of the control group [(51.59±15.19) and (50.51±15.52), respectively; all <em>P</em>&lt;0.05]. The total score of hope level in the observation group was (40.87±6.03), which was higher than that in the control group [(34.78±5.93); <em>P</em>&lt;0.05]. The scores of all 8 dimensions of health status in the observation group were higher than those in the control group (all <em>P</em>&lt;0.05). The nursing satisfaction rate of the observation group was 92.77%, which was higher than 78.31% of the control group (<em>P</em>&lt;0.05).</div></div><div><h3>Conclusion</h3><div>Implementing holistic nursing intervention based on Harmonious Nursing Theory for patients in stroke recovery period can effectively alleviate negative emotions, improve hope level and quality of life, as well as enhance nursing satisfaction, which has high clinical promotion value.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 12","pages":"Article 108507"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145623650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A urine-based point-of-care test for Factor Xa inhibitors in acute stroke management 基于尿液的Xa因子抑制剂在急性卒中管理中的即时检测
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-12-01 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108500
Prasen R Marella , Jacob A Sambursky , Kriti Bhayana , Asha P Jacob , Varsha Muddasani , Murli Mishra , Alexandra L Czap , James C Grotta

Background

For stroke patients with history of possible Direct Acting Oral Anticoagulant use, clinicians must make treatment decisions without knowledge of whether the patient is therapeutically anticoagulated. A urine-based point-of-care test might help guide these emergency decisions.

Methods

We prospectively enrolled patients with suspected recent factor-Xa-inhibitor (Xai) use being evaluated for acute stroke therapy in an urban teaching hospital. We obtained the urine test and plasma anti-Xa level in parallel with usual clinical management; the treating clinician did not use test results for decision-making but recorded treatment they would have given had they known the urine test was accurate. The primary outcome was feasibility. Secondary outcomes were accuracy of the urine test at plasma anti-Xa level >30 ng/mL and consequent change in clinical management.

Results

Twenty-one patients were enrolled over 1 year. The urine test was successfully carried out in all patients, median 59 minutes after Emergency Department arrival. Sensitivity and specificity for the urine test to detect threshold anti-Xa activity were 100 % and 87.5 %. Of 20 patients with ischemic stroke, none of whom were treated with thrombolytics, 6 had a negative test which would have resulted in treatment of 4 (66 %).

Conclusion

A urine point-of-care test for Xai activity is feasible, accurate, and would likely result in treatment of stroke patients currently excluded from thrombolysis.
背景:对于可能有直接作用口服抗凝药物使用史的脑卒中患者,临床医生必须在不知道患者是否在治疗性抗凝的情况下做出治疗决定。基于尿液的即时检测可能有助于指导这些紧急决策。方法:我们前瞻性地招募了一家城市教学医院疑似近期使用因子- xa抑制剂(Xai)治疗急性脑卒中的患者。尿检和血浆抗xa水平与临床常规管理并行;治疗的临床医生没有使用测试结果来做决策,而是记录了如果他们知道尿检是准确的,他们会给予的治疗。主要结果是可行性。次要结果为血浆抗xa水平> ~ 30ng /mL尿检的准确性以及由此引起的临床管理变化。结果:21例患者入组1年以上。所有患者在急诊室到达后平均59分钟成功进行尿液检查。尿液检测阈值抗xa活性的敏感性为100%,特异性为87.5%。在20例缺血性卒中患者中,没有人接受溶栓治疗,其中6例检测呈阴性,这将导致4例(66%)的治疗。结论:尿液即时检测Xai活性是可行的,准确的,并且可能导致目前排除溶栓的脑卒中患者的治疗。
{"title":"A urine-based point-of-care test for Factor Xa inhibitors in acute stroke management","authors":"Prasen R Marella ,&nbsp;Jacob A Sambursky ,&nbsp;Kriti Bhayana ,&nbsp;Asha P Jacob ,&nbsp;Varsha Muddasani ,&nbsp;Murli Mishra ,&nbsp;Alexandra L Czap ,&nbsp;James C Grotta","doi":"10.1016/j.jstrokecerebrovasdis.2025.108500","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108500","url":null,"abstract":"<div><h3>Background</h3><div>For stroke patients with history of possible Direct Acting Oral Anticoagulant use, clinicians must make treatment decisions without knowledge of whether the patient is therapeutically anticoagulated. A urine-based point-of-care test might help guide these emergency decisions.</div></div><div><h3>Methods</h3><div>We prospectively enrolled patients with suspected recent factor-Xa-inhibitor (Xai) use being evaluated for acute stroke therapy in an urban teaching hospital. We obtained the urine test and plasma anti-Xa level in parallel with usual clinical management; the treating clinician did not use test results for decision-making but recorded treatment they would have given had they known the urine test was accurate. The primary outcome was feasibility. Secondary outcomes were accuracy of the urine test at plasma anti-Xa level &gt;30 ng/mL and consequent change in clinical management.</div></div><div><h3>Results</h3><div>Twenty-one patients were enrolled over 1 year. The urine test was successfully carried out in all patients, median 59 minutes after Emergency Department arrival. Sensitivity and specificity for the urine test to detect threshold anti-Xa activity were 100 % and 87.5 %. Of 20 patients with ischemic stroke, none of whom were treated with thrombolytics, 6 had a negative test which would have resulted in treatment of 4 (66 %).</div></div><div><h3>Conclusion</h3><div>A urine point-of-care test for Xai activity is feasible, accurate, and would likely result in treatment of stroke patients currently excluded from thrombolysis.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 12","pages":"Article 108500"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145582808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public awareness of stroke risk factors in high-income countries: A systematic review 高收入国家公众对中风危险因素的认识:一项系统回顾。
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2025-12-01 DOI: 10.1016/j.jstrokecerebrovasdis.2025.108501
Mc Lernon S , Appiah B , Moorley C , Thomas N , Mussa R , Gonzales S , Werring D , Olawade D․B , Flood C

Purpose

Stroke remains a significant health concern in high-income countries (HICs) and is increasing among younger adults. Although largely preventable, public awareness of stroke risk factors in HICs is not well established. We assessed awareness levels in World Bank-classified HICs and identified associated factors.

Methods

Systematic searches used Ovid MEDLINE, PsycINFO, Academic Search Complete, CINAHL, Cochrane Review Library, Emcare, and ASSIA. Two authors independently screened studies and extracted data. Risk of bias was assessed using Critical Appraisal Skills Programme checklists. Due to heterogeneity, narrative synthesis was conducted. Exploratory analyses including visual mapping and descriptive cross-country comparisons were performed despite methodological heterogeneity. Protocol registered on PROSPERO (CRD42025621931).

Findings

Of 2146 papers screened, 23 met inclusion criteria. Most studies reported low stroke risk factor awareness. Hypertension was most frequently identified, followed by smoking, dyslipidaemia, and diabetes. Sedentary lifestyle, alcohol consumption, ethnicity, and atrial fibrillation were least recognised. Risk of bias assessment revealed sampling and generalisability concerns in most studies. Most reported associations were unadjusted for potential confounders. Higher education was linked to greater awareness. Marked geographical clustering occurred, with 65 % of studies from Middle Eastern countries, predominantly Saudi Arabia.

Discussion

This review uniquely identifies critical evidence gaps including under-representation of diverse populations, lack of standardised awareness metrics, and predominance of unadjusted analyses in HIC stroke risk factor awareness research.

Conclusion

Stroke risk factor awareness gaps are prevalent and may limit prevention efforts. Large-scale, methodologically robust studies across diverse geographical, socioeconomic, and ethnic populations within HICs are urgently needed, as awareness characteristics may vary dramatically even within high-income settings. Targeted education is necessary for primary prevention strategies.
目的:卒中在高收入国家(HICs)仍然是一个重要的健康问题,并且在年轻人中正在增加。虽然在很大程度上是可以预防的,但公众对高收入国家中风危险因素的认识还没有很好地建立起来。我们评估了世界银行分类的高收入国家的意识水平,并确定了相关因素。方法:使用Ovid MEDLINE、PsycINFO、Academic Search Complete、CINAHL、Cochrane Review Library、Emcare和ASSIA进行系统检索。两位作者独立筛选研究并提取数据。使用关键评估技能项目清单评估偏倚风险。由于异质性,进行了叙事综合。尽管方法存在异质性,但仍进行了探索性分析,包括视觉制图和描述性跨国比较。在PROSPERO上注册的协议(CRD42025621931)。结果:在筛选的2146篇论文中,23篇符合纳入标准。大多数研究报告显示,人们对中风危险因素的认识较低。最常见的是高血压,其次是吸烟、血脂异常和糖尿病。久坐不动的生活方式、饮酒、种族和心房颤动是最不被认可的。偏倚风险评估揭示了大多数研究的抽样和普遍性问题。大多数报道的关联都没有考虑潜在的混杂因素。高等教育与更强的意识联系在一起。出现了明显的地理聚类,65%的研究来自中东国家,主要是沙特阿拉伯。讨论:本综述独特地确定了关键的证据差距,包括不同人群的代表性不足,缺乏标准化的意识指标,以及在HIC卒中危险因素意识研究中未调整分析的优势。结论:卒中危险因素认识差距普遍存在,可能限制预防工作。迫切需要在高收入国家的不同地理、社会经济和种族人群中进行大规模、方法学上可靠的研究,因为即使在高收入环境中,意识特征也可能存在巨大差异。有针对性的教育对于初级预防战略是必要的。
{"title":"Public awareness of stroke risk factors in high-income countries: A systematic review","authors":"Mc Lernon S ,&nbsp;Appiah B ,&nbsp;Moorley C ,&nbsp;Thomas N ,&nbsp;Mussa R ,&nbsp;Gonzales S ,&nbsp;Werring D ,&nbsp;Olawade D․B ,&nbsp;Flood C","doi":"10.1016/j.jstrokecerebrovasdis.2025.108501","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2025.108501","url":null,"abstract":"<div><h3>Purpose</h3><div>Stroke remains a significant health concern in high-income countries (HICs) and is increasing among younger adults. Although largely preventable, public awareness of stroke risk factors in HICs is not well established. We assessed awareness levels in World Bank-classified HICs and identified associated factors.</div></div><div><h3>Methods</h3><div>Systematic searches used Ovid MEDLINE, PsycINFO, Academic Search Complete, CINAHL, Cochrane Review Library, Emcare, and ASSIA. Two authors independently screened studies and extracted data. Risk of bias was assessed using Critical Appraisal Skills Programme checklists. Due to heterogeneity, narrative synthesis was conducted. <strong>Exploratory analyses including visual mapping and descriptive cross-country comparisons were performed despite methodological heterogeneity.</strong> Protocol registered on PROSPERO (CRD42025621931).</div></div><div><h3>Findings</h3><div>Of 2146 papers screened, 23 met inclusion criteria. Most studies reported low stroke risk factor awareness. Hypertension was most frequently identified, followed by smoking, dyslipidaemia, and diabetes. Sedentary lifestyle, alcohol consumption, ethnicity, and atrial fibrillation were least recognised. <strong>Risk of bias assessment revealed sampling and generalisability concerns in most studies. Most reported associations were unadjusted for potential confounders.</strong> Higher education was linked to greater awareness. <strong>Marked geographical clustering occurred, with 65 % of studies from Middle Eastern countries, predominantly Saudi Arabia.</strong></div></div><div><h3>Discussion</h3><div>This review uniquely identifies critical evidence gaps including under-representation of diverse populations, lack of standardised awareness metrics, and predominance of unadjusted analyses in HIC stroke risk factor awareness research.</div></div><div><h3>Conclusion</h3><div>Stroke risk factor awareness gaps are prevalent and may limit prevention efforts. <strong>Large-scale, methodologically robust studies across diverse geographical, socioeconomic, and ethnic populations within HICs are urgently needed, as awareness characteristics may vary dramatically even within high-income settings.</strong> Targeted education is necessary for primary prevention strategies.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"34 12","pages":"Article 108501"},"PeriodicalIF":1.8,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145592709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Stroke & Cerebrovascular Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1